foxo4 dri senolytic mice baar 2017

foxo4 dri senolytic mice baar 2017 Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell Development of a novel senolytic

Name: foxo4 dri senolytic mice baar 2017 Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell Development of a novel senolytic
Brand: psychiatrist-in-kuwait.com
SKU: 1468026431
Price: 26.88 USD
Availability: InStock
Rating: 4.6606000000000005 (24 reviews)

Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI 10mg vial Description RCpeptides Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Peptide targeting senescent cells restores stamina, fur, and kidney function in old mice FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data

SKU: 1468026431 · From psychiatrist-in-kuwait.com

4.7

USD26.88 USD68.88

Pay in 4 interest-free payments of $6.72 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Reference: ARA16 ARA 290 16mg ARA-290 (aka Cibinetide) is a synthetic peptide derived from erythropoietin (EPO) designed to activate the innate repair receptor (IRR) and produce anti-inflammatory, neuroprotective, and tissue-repair effects without EPOs red bood-cell-stimulating or pro-thrombotic actions